Streamlining temperate phage engineering to facilitate precise in situ manipulation of gut microbiota

简化温带噬菌体工程以促进肠道微生物群的精确原位操作

基本信息

项目摘要

PROJECT SUMMARY This project aims to improve the overall accessibility of precise tools for manipulating mammalian microbiota within native gut environments, i.e., in situ. Despite the rich microbial diversity that mammalian gut communities natively acquire and maintain over time, the feasibility of experimentally and therapeutically altering their composition with antibiotics or fecal transplants has been clearly documented. However, these widely available treatments are found to broadly alter microbiome composition and this has limited their practical utility for determining how particular populations of microbiota influence their host’s health. Alternative approaches that allow for precise elimination or genetic editing of endogenous gut commensals in situ have recently been demonstrated using horizontally transmissible mobile genetic elements (MGEs), including temperate phages, but are not yet widely established. Phages are thought to be among the most precise MGEs for in situ microbiome manipulation given that the majority of studies on their host range have failed to detect cross-genus infectivity. Studies proposed in this application harness the natural abundance and precision of temperate phages and will establish generalizable methods to re-engineer them for more reliable use in microbiome editing applications. Namely, my proposed directed evolution and rational engineering approaches will streamline the generation of (1) lethal virulent mutants that are obligately lytic and capable of superinfecting their lysogenic kin, as well as (2) non-lethal temperate phage derivatives that can eliminate endogenous prophages or stably lysogenize at elevated frequencies. The initial mentored K99 phase of this research includes proof-of-principle engineering experiments with lambda, the most well-characterized temperate phage of Escherichia coli. In addition to providing me with hands-on lambda experience, this vital K99 training will prepare me for independent research activities during the R00 phase and throughout my future career by allowing me to become skilled in key techniques—such as large-scale DNA assembly in yeast for construction of phage genome libraries and whole phage genome sequencing—that can be applied to the study of non-model microbiota. Training will be supervised by two mentors with the requisite resources and experience to ensure my success on this project, Dr. Jef Boeke and Dr. Marcus Noyes, as well as four advisory committee members with complementary expertise. Career-oriented guidance from my mentors and advisors, along with career development activities during the K99 phase that include formal coursework on grant writing and project management, will further facilitate my transition to the R00 phase and my long-term productivity as an independent academic investigator. Ultimately, completion of this proposed project will open new avenues for well-controlled experimentation in the microbiome field while providing fundamental tools for microbial genome engineering and laying a strong foundation for my future lab’s research program.
项目摘要 该项目旨在提高操纵哺乳动物微生物的精确工具的总体可及性 在本地肠道环境中,即原位。尽管哺乳动物肠道社区具有丰富的微生物多样性 随着时间的流逝,本来就获得和维持的,在实验和治疗上的可行性 已清楚地记录了具有抗生素或粪便移植物的组成。但是,这些广泛可用 发现治疗可广泛改变微生物组的组成,这限制了其实际实用性 确定特定的微生物群如何影响宿主的健康。替代方法 最近允许精确消除或遗传性肠道肠道原位的原位 使用水平传播的移动遗传元件(MGE)证明,包括温度噬菌体, 但尚未广泛建立。噬菌体被认为是原位微生物组最精确的MGE 鉴于大多数关于其宿主范围的研究未能检测到跨发感染的操作。 在此应用中提出的研究可以利用温度噬菌体的自然抽象和精度 建立可通用的方法来重新设计它们,以在微生物组编辑应用中更可靠地使用。 也就是说,我提出的定向进化和合理的工程方法将简化生成 (1)具有强制性裂解并且能够超级感染的致命病毒突变体以及(2) 非致命的温度噬菌体衍生物,可以消除内源性或稳定的溶菌原 频率升高。最初修补了这项研究的K99阶段包括原则工程证明 Lambda的实验,这是大肠杆菌中最良好的温度噬菌体。此外 为我提供动手的Lambda经验,这种重要的K99培训将为我准备独立研究 在R00阶段和整个未来职业的活动,使我能够熟练掌握关键 技术 - 酵母中的大规模DNA组件,用于噬菌体基因组库和整个 噬菌体基因组测序 - 可以应用于非模型菌群的研究。培训将是 由两位导师的监督,具有所需的资源和经验,以确保我在这个项目上的成功, Jef Boeke博士和Marcus Noyes博士,以及四名咨询委员会成员 专业知识。我的导师和顾问的面向职业指导以及职业发展活动 在K99阶段,包括赠款写作和项目管理的正式课程,将进一步 促进了我向R00阶段的过渡以及作为独立学术研究者的长期生产力。 最终,该拟议项目的完成将为实验良好的实验开辟新的途径 微生物组领域在提供微生物基因组工程的基本工具并铺设强大的工具 我未来实验室研究计划的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Gregory William Go...的其他基金

Streamlining temperate phage engineering to facilitate precise in situ manipulation of gut microbiota
简化温带噬菌体工程以促进肠道微生物群的精确原位操作
  • 批准号:
    10507364
    10507364
  • 财政年份:
    2022
  • 资助金额:
    $ 12.5万
    $ 12.5万
  • 项目类别:
Exploiting simultaneous positive and negative selection to advance directed evolution of orthogonal RNA-guided nucleases
利用同时正向和负向选择来推进正交 RNA 引导核酸酶的定向进化
  • 批准号:
    10133453
    10133453
  • 财政年份:
    2020
  • 资助金额:
    $ 12.5万
    $ 12.5万
  • 项目类别:

相似国自然基金

结合态抗生素在水产品加工过程中的消解机制与产物毒性解析
  • 批准号:
    32302247
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于Fe-N-BC/PMS体系的自由基与非自由基协同降解地下水中磺胺类抗生素的机制研究
  • 批准号:
    42377036
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于高通量测序和培养组学的伴侣动物-人抗生素抗性基因分布特征及传播研究
  • 批准号:
    82373646
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
微藻-细菌协同降解抗生素及其共适应机制
  • 批准号:
    42377367
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
多环芳烃影响大肠杆菌抗生素耐药性进化的分子机制
  • 批准号:
    32301424
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Streamlining temperate phage engineering to facilitate precise in situ manipulation of gut microbiota
简化温带噬菌体工程以促进肠道微生物群的精确原位操作
  • 批准号:
    10507364
    10507364
  • 财政年份:
    2022
  • 资助金额:
    $ 12.5万
    $ 12.5万
  • 项目类别:
The Gut Microbiome in Carbapenem-Resistant Enterobacteriaceae Colonization, Persistence, Infection, and Tolerance after Lung or Liver Transplantation
肺或肝移植后耐碳青霉烯类肠杆菌科细菌的定植、持久性、感染和耐受性中的肠道微生物组
  • 批准号:
    10548144
    10548144
  • 财政年份:
    2021
  • 资助金额:
    $ 12.5万
    $ 12.5万
  • 项目类别:
The Gut Microbiome in Carbapenem-Resistant Enterobacteriaceae Colonization, Persistence, Infection, and Tolerance after Lung or Liver Transplantation
肺或肝移植后耐碳青霉烯类肠杆菌科细菌的定植、持久性、感染和耐受性中的肠道微生物组
  • 批准号:
    10214154
    10214154
  • 财政年份:
    2021
  • 资助金额:
    $ 12.5万
    $ 12.5万
  • 项目类别:
The Gut Microbiome in Carbapenem-Resistant Enterobacteriaceae Colonization, Persistence, Infection, and Tolerance after Lung or Liver Transplantation
肺或肝移植后耐碳青霉烯类肠杆菌科细菌的定植、持久性、感染和耐受性中的肠道微生物组
  • 批准号:
    10357963
    10357963
  • 财政年份:
    2021
  • 资助金额:
    $ 12.5万
    $ 12.5万
  • 项目类别:
Guideline Implementation to Decrease Inappropriate Bacteriuria Treatment
减少不适当菌尿治疗的指南实施
  • 批准号:
    8600170
    8600170
  • 财政年份:
    2010
  • 资助金额:
    $ 12.5万
    $ 12.5万
  • 项目类别: